Skip to main content
Top
Published in: BMC Infectious Diseases 1/2013

Open Access 01-12-2013 | Research article

The spectrum of acute bacterial meningitis in elderly patients

Authors: Pere Domingo, Virginia Pomar, Natividad de Benito, Pere Coll

Published in: BMC Infectious Diseases | Issue 1/2013

Login to get access

Abstract

Background

We conducted a prospective, observational study in Barcelona to determine the epidemiology, clinical features, and outcome of elderly patients with acute bacterial meningitis (ABM) compared with younger adults.

Methods

During 1982–2010, all patients with ABM were prospectively evaluated. There were two groups: I (15–64 years) and II (≥ 65 years). All patients underwent clinical examination on admission and at discharge following a predefined protocol.

Results

We evaluated 635 episodes of ABM. The incidence was 4.03/100,000 (Group I) and 7.40 /100,000 inhabitants/year (Group II) (RR = 1.84; 95%CI: 1.56–2.17, P < 0.0001). Elderly patients had co-morbid conditions more frequently (P < 0.0001) and more frequently lacked fever (P = 0.0625), neck stiffness (P < 0.0001) and skin rash (P < 0.0001), but had an altered level of consciousness more often (P < 0.0001). The interval admission-start of antibiotic therapy was longer for elderly patients (P < 0.0001). Meningococcal meningitis was less frequent in elderly patients (P < 0.0001), whereas listerial (P = 0.0196), gram-negative bacillary (P = 0.0065), and meningitis of unknown origin (P = 0.0076) were more frequent. Elderly patients had a higher number of neurologic (P = 0.0009) and extra-neurologic complications (P < 0.0001). The overall mortality ratio was higher in elderly patients (P < 0.0001).

Conclusions

Elderly people are at higher risk of having ABM than younger adults. ABM in the elderly presents with co-morbid conditions, is clinically subtler, has a longer interval admission-antibiotic therapy, and has non-meningococcal etiology. It is associated with an earlier and higher mortality rate than in younger patients.
Appendix
Available only for authorised users
Literature
1.
go back to reference Morris SK, Moss WJ, Halsey N: Haemophilus influenzae type b conjugate vaccine use and effectiveness. Lancet Infect Dis. 2008, 8: 435-443. 10.1016/S1473-3099(08)70152-X.CrossRefPubMed Morris SK, Moss WJ, Halsey N: Haemophilus influenzae type b conjugate vaccine use and effectiveness. Lancet Infect Dis. 2008, 8: 435-443. 10.1016/S1473-3099(08)70152-X.CrossRefPubMed
2.
go back to reference Thigpen MC, Whitney CG, Messonnier NE, Zell ER, Lynfield R, Hadler JL, Harrison LH, Farley MM, Reingold A, Bennett NM, Craig AS, Schaffner W, Thomas A, Lewis MM, Scallan E, Schuchat A: Bacterial meningitis in the United States, 1998–2007. N Engl J Med. 2011, 364: 2016-2025. 10.1056/NEJMoa1005384.CrossRefPubMed Thigpen MC, Whitney CG, Messonnier NE, Zell ER, Lynfield R, Hadler JL, Harrison LH, Farley MM, Reingold A, Bennett NM, Craig AS, Schaffner W, Thomas A, Lewis MM, Scallan E, Schuchat A: Bacterial meningitis in the United States, 1998–2007. N Engl J Med. 2011, 364: 2016-2025. 10.1056/NEJMoa1005384.CrossRefPubMed
3.
go back to reference Verani JR, Schrag SJ: Group B streptococcal disease in infants: progress in prevention and continued challenges. Clin Perinatol. 2010, 37: 375-392. 10.1016/j.clp.2010.02.002.CrossRefPubMed Verani JR, Schrag SJ: Group B streptococcal disease in infants: progress in prevention and continued challenges. Clin Perinatol. 2010, 37: 375-392. 10.1016/j.clp.2010.02.002.CrossRefPubMed
4.
go back to reference Brouwer MC, Tunkel AR, van de Beek D: Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clin Microbiol. 2010, 23: 467-492. 10.1128/CMR.00070-09.CrossRef Brouwer MC, Tunkel AR, van de Beek D: Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clin Microbiol. 2010, 23: 467-492. 10.1128/CMR.00070-09.CrossRef
5.
go back to reference Meningococcal Disease Surveillance Group: Meningococcal disease: secondary attack rate and chemoprophylaxis in the United States, 1974. JAMA. 1976, 235: 261-265.CrossRef Meningococcal Disease Surveillance Group: Meningococcal disease: secondary attack rate and chemoprophylaxis in the United States, 1974. JAMA. 1976, 235: 261-265.CrossRef
6.
go back to reference Tang L, Chen S, Hsu W, Lyu RK: Acute bacterial meningitis in adults: a hospital-based epidemiological study. QJM. 1999, 92: 719-725. 10.1093/qjmed/92.12.719.CrossRefPubMed Tang L, Chen S, Hsu W, Lyu RK: Acute bacterial meningitis in adults: a hospital-based epidemiological study. QJM. 1999, 92: 719-725. 10.1093/qjmed/92.12.719.CrossRefPubMed
7.
go back to reference Durand ML, Calderwood S, Weber D, Miller SI, Southwick FS, Caviness VS, Swartz MN: Acute Bacterial meningitis in Adults. A review of 493 episodes. N Engl J Med. 1993, 328: 21-28. 10.1056/NEJM199301073280104.CrossRefPubMed Durand ML, Calderwood S, Weber D, Miller SI, Southwick FS, Caviness VS, Swartz MN: Acute Bacterial meningitis in Adults. A review of 493 episodes. N Engl J Med. 1993, 328: 21-28. 10.1056/NEJM199301073280104.CrossRefPubMed
8.
go back to reference Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA: Manual of Clinical Microbiology. 2007, Washington DC: ASM Press, 9 Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA: Manual of Clinical Microbiology. 2007, Washington DC: ASM Press, 9
9.
go back to reference National Committee for Clinical Laboratory Standards: Performance standards for antimicrobial disc susceptibility test. 1990, M2-A4 Vilanova, PA: NCCLS National Committee for Clinical Laboratory Standards: Performance standards for antimicrobial disc susceptibility test. 1990, M2-A4 Vilanova, PA: NCCLS
10.
go back to reference National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically. 1990, M7-A2 Vilanova, PA: NCCLS National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically. 1990, M7-A2 Vilanova, PA: NCCLS
11.
go back to reference Clinical and Laboratory Standards Institute (CLSI): Performance standards for antimicrobial susceptibility testing: Eighteenth Informational Supplement. M100-S18. 2008, Wayne, PA: CLSI Clinical and Laboratory Standards Institute (CLSI): Performance standards for antimicrobial susceptibility testing: Eighteenth Informational Supplement. M100-S18. 2008, Wayne, PA: CLSI
12.
go back to reference Barquet N, Domingo P, Caylà JA, González J, Rodrigo C, Fernández-Viladrich P, Moraga-Llop FA, Marco F, Vázquez J, Sáez-Nieto JA, Casal J, Canela J, Foz M: Meningococcal disease in a large urban population (Barcelona, 1987–1992). Predictors of dismal prognosis. Arch Intern Med. 1999, 159: 2329-2340. 10.1001/archinte.159.19.2329.CrossRefPubMed Barquet N, Domingo P, Caylà JA, González J, Rodrigo C, Fernández-Viladrich P, Moraga-Llop FA, Marco F, Vázquez J, Sáez-Nieto JA, Casal J, Canela J, Foz M: Meningococcal disease in a large urban population (Barcelona, 1987–1992). Predictors of dismal prognosis. Arch Intern Med. 1999, 159: 2329-2340. 10.1001/archinte.159.19.2329.CrossRefPubMed
13.
go back to reference World Health Organization: International Guide for monitoring alcohol consumption and related harm. 2000, Geneva: World Health Organization World Health Organization: International Guide for monitoring alcohol consumption and related harm. 2000, Geneva: World Health Organization
14.
go back to reference Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987, 140: 373-383.CrossRef Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987, 140: 373-383.CrossRef
15.
go back to reference Domingo P, Barquet N, Alvarez M, Coll P, Nava J, Garau J: Group B streptococcal meningitis in adults: report of twelve cases and review. Clin Infect Dis. 1997, 25: 1180-1187. 10.1086/516094.CrossRefPubMed Domingo P, Barquet N, Alvarez M, Coll P, Nava J, Garau J: Group B streptococcal meningitis in adults: report of twelve cases and review. Clin Infect Dis. 1997, 25: 1180-1187. 10.1086/516094.CrossRefPubMed
16.
go back to reference Lu CH, Chang WN, Chuang YC, Chang HW: The prognostic factors of adult Gram-negative bacillary meningitis. J Hosp Infect. 1998, 40: 27-34.CrossRefPubMed Lu CH, Chang WN, Chuang YC, Chang HW: The prognostic factors of adult Gram-negative bacillary meningitis. J Hosp Infect. 1998, 40: 27-34.CrossRefPubMed
17.
18.
go back to reference Pfister H, Leiden W, Einhaupl K: Spectrum of complications during bacterial meningitis in adults. Results of a prospective clinical study. Arch Neurol. 1993, 50: 575-581. 10.1001/archneur.1993.00540060015010.CrossRefPubMed Pfister H, Leiden W, Einhaupl K: Spectrum of complications during bacterial meningitis in adults. Results of a prospective clinical study. Arch Neurol. 1993, 50: 575-581. 10.1001/archneur.1993.00540060015010.CrossRefPubMed
19.
go back to reference Brandtzaeg P, Kierulf P, Gaustad P, Skulberg A, Bruun JN, Halvorsen S, Sørensen E: Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J Infect Dis. 1989, 159: 195-204. 10.1093/infdis/159.2.195.CrossRefPubMed Brandtzaeg P, Kierulf P, Gaustad P, Skulberg A, Bruun JN, Halvorsen S, Sørensen E: Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J Infect Dis. 1989, 159: 195-204. 10.1093/infdis/159.2.195.CrossRefPubMed
20.
go back to reference Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R: The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994, 149 (3 Pt 1): 818-824.CrossRefPubMed Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R: The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994, 149 (3 Pt 1): 818-824.CrossRefPubMed
21.
go back to reference Knaus WA, Wagner DP, Draper EA: The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalised adults. Chest. 1997, 1100: 1619-1636. Knaus WA, Wagner DP, Draper EA: The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalised adults. Chest. 1997, 1100: 1619-1636.
22.
go back to reference Barquet N, Domingo P, Caylà JA, González J, Rodrigo C, Fernández-Viladrich P, Moraga-Llop FA, Marco F, Vázquez J, Sáez-Nieto JA, Casal J, Canela J, Foz M: Prognostic factors in meningococcal disease. Development of a bedside predictive model and scoring system. Barcelona Meningococcal Disease Surveillance Group. JAMA. 1997, 278: 491-496. 10.1001/jama.1997.03550060067038.CrossRefPubMed Barquet N, Domingo P, Caylà JA, González J, Rodrigo C, Fernández-Viladrich P, Moraga-Llop FA, Marco F, Vázquez J, Sáez-Nieto JA, Casal J, Canela J, Foz M: Prognostic factors in meningococcal disease. Development of a bedside predictive model and scoring system. Barcelona Meningococcal Disease Surveillance Group. JAMA. 1997, 278: 491-496. 10.1001/jama.1997.03550060067038.CrossRefPubMed
23.
go back to reference McMillan DA, Lin CY, Aronin SI, Quagliarello VJ: Community-acquired bacterial meningitis in adults: categorization of causes and timing of death. Clin Infect Dis. 2001, 33: 969-975. 10.1086/322612.CrossRefPubMed McMillan DA, Lin CY, Aronin SI, Quagliarello VJ: Community-acquired bacterial meningitis in adults: categorization of causes and timing of death. Clin Infect Dis. 2001, 33: 969-975. 10.1086/322612.CrossRefPubMed
24.
go back to reference Martínez AI, Dominguez A, Oviedo M, Minguell S, Jansa JM, Codina G, Vazquez JA: Changes in the evolution of meningococcal disease, 2001–2008, Catalonia (Spain). Vaccine. 2009, 27: 3496-3498. 10.1016/j.vaccine.2009.01.045.CrossRefPubMed Martínez AI, Dominguez A, Oviedo M, Minguell S, Jansa JM, Codina G, Vazquez JA: Changes in the evolution of meningococcal disease, 2001–2008, Catalonia (Spain). Vaccine. 2009, 27: 3496-3498. 10.1016/j.vaccine.2009.01.045.CrossRefPubMed
25.
go back to reference Cohn AC, MacNeil JR, Harrison LH, Hatcher C, Theodore J, Schmidt M, Pondo T, Arnold KE, Baumbach J, Bennett N, Craig AS, Farley M, Gershman K, Petit S, Lynfield R, Reingold A, Schaffner W, Shutt KA, Zell ER, Mayer LW, Clark T, Stephens D, Messonnier NE: Changes in Neisseria meningitidis disease epidemiology in the United States, 1998–2007: implications for prevention of meningococcal disease. Clin Infect Dis. 2010, 50: 184-191. 10.1086/649209.CrossRefPubMed Cohn AC, MacNeil JR, Harrison LH, Hatcher C, Theodore J, Schmidt M, Pondo T, Arnold KE, Baumbach J, Bennett N, Craig AS, Farley M, Gershman K, Petit S, Lynfield R, Reingold A, Schaffner W, Shutt KA, Zell ER, Mayer LW, Clark T, Stephens D, Messonnier NE: Changes in Neisseria meningitidis disease epidemiology in the United States, 1998–2007: implications for prevention of meningococcal disease. Clin Infect Dis. 2010, 50: 184-191. 10.1086/649209.CrossRefPubMed
26.
go back to reference Trotter CL, Chandra M, Cano R, Larrauri A, Ramsay ME, Brehony C, Jolley KA, Maiden MC, Heuberger S, Frosch M: A surveillance network for meningococcal disease in Europe. FEMS Microbiol Rev. 2007, 31: 27-36. 10.1111/j.1574-6976.2006.00060.x.CrossRefPubMed Trotter CL, Chandra M, Cano R, Larrauri A, Ramsay ME, Brehony C, Jolley KA, Maiden MC, Heuberger S, Frosch M: A surveillance network for meningococcal disease in Europe. FEMS Microbiol Rev. 2007, 31: 27-36. 10.1111/j.1574-6976.2006.00060.x.CrossRefPubMed
29.
go back to reference Ferguson R: The effect of antibiotic therapy before admission to hospital on recognition of the causative organism in acute bacterial meningitis. J Infect. 1986, 13: 241-244. 10.1016/S0163-4453(86)91157-6.CrossRefPubMed Ferguson R: The effect of antibiotic therapy before admission to hospital on recognition of the causative organism in acute bacterial meningitis. J Infect. 1986, 13: 241-244. 10.1016/S0163-4453(86)91157-6.CrossRefPubMed
30.
go back to reference Peltola H: Meningococcal disease: still with us. Rev Infect Dis. 1983, 5: 71-91. 10.1093/clinids/5.1.71.CrossRefPubMed Peltola H: Meningococcal disease: still with us. Rev Infect Dis. 1983, 5: 71-91. 10.1093/clinids/5.1.71.CrossRefPubMed
31.
go back to reference Schwartz B, Moore PS, Broome CV: Global epidemiology of meningococcal disease. Clin Microbiol Rev. 1989, 2: 118S-124S.CrossRef Schwartz B, Moore PS, Broome CV: Global epidemiology of meningococcal disease. Clin Microbiol Rev. 1989, 2: 118S-124S.CrossRef
32.
go back to reference Cartwright K, Noah N, Peltola H, the Meningococcal Advisory Board: Meningococcal disease in Europe: epidemiology, mortality, and prevention with conjugate vaccines. Vaccine. 2001, 19: 4347-4356. 10.1016/S0264-410X(01)00205-5.CrossRefPubMed Cartwright K, Noah N, Peltola H, the Meningococcal Advisory Board: Meningococcal disease in Europe: epidemiology, mortality, and prevention with conjugate vaccines. Vaccine. 2001, 19: 4347-4356. 10.1016/S0264-410X(01)00205-5.CrossRefPubMed
33.
go back to reference Salleras L, Dominguez A, Cardeñosa N: Impact of mass vaccination with polysaccharide conjugate vaccine against serogroup C meningococcal disease in Spain. Vaccine. 2003, 21: 725-728. 10.1016/S0264-410X(02)00589-3.CrossRefPubMed Salleras L, Dominguez A, Cardeñosa N: Impact of mass vaccination with polysaccharide conjugate vaccine against serogroup C meningococcal disease in Spain. Vaccine. 2003, 21: 725-728. 10.1016/S0264-410X(02)00589-3.CrossRefPubMed
34.
go back to reference Trotter CL, Maiden MC: Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs. Expert Rev Vaccines. 2009, 8: 851-861. 10.1586/erv.09.48.CrossRefPubMedPubMedCentral Trotter CL, Maiden MC: Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs. Expert Rev Vaccines. 2009, 8: 851-861. 10.1586/erv.09.48.CrossRefPubMedPubMedCentral
35.
go back to reference Bohr V, Rasmussen N, Hansen B, Kjersem H, Jessen O, Johnsen N, Kristensen HS: 875 cases of bacterial meningitis: diagnostic procedures and the impact of preadmission antibiotic therapy. Part III of a three-part series. J Infect. 1983, 7: 193-202. 10.1016/S0163-4453(83)96980-3.CrossRefPubMed Bohr V, Rasmussen N, Hansen B, Kjersem H, Jessen O, Johnsen N, Kristensen HS: 875 cases of bacterial meningitis: diagnostic procedures and the impact of preadmission antibiotic therapy. Part III of a three-part series. J Infect. 1983, 7: 193-202. 10.1016/S0163-4453(83)96980-3.CrossRefPubMed
36.
go back to reference Proulx N, Fréchette D, Toye B, Chan J, Kravcik S: Delays in the administration of antibiotics are associated with mortality from adult acute bacterial meningitis. QJM. 2005, 98: 291-298. 10.1093/qjmed/hci047.CrossRefPubMed Proulx N, Fréchette D, Toye B, Chan J, Kravcik S: Delays in the administration of antibiotics are associated with mortality from adult acute bacterial meningitis. QJM. 2005, 98: 291-298. 10.1093/qjmed/hci047.CrossRefPubMed
37.
go back to reference Erdem H, Kilic S, Coskun O, Ersoy Y, Cagatay A, Onguru P, Alp S, Members of the Turkish Bacterial Meningitis in the Elderly Study Group: Community-acquired acute bacterial meningitis in the elderly in Turkey. Clin Microbiol Infect. 2010, 16: 1223-1229.CrossRefPubMed Erdem H, Kilic S, Coskun O, Ersoy Y, Cagatay A, Onguru P, Alp S, Members of the Turkish Bacterial Meningitis in the Elderly Study Group: Community-acquired acute bacterial meningitis in the elderly in Turkey. Clin Microbiol Infect. 2010, 16: 1223-1229.CrossRefPubMed
38.
go back to reference Lai WA, Chen SF, Tsai NW, Chang CC, Chang WN, Lu CH, Chuang YC, Chien CC, Huang CR: Clinical characteristics and prognosis of acute bacterial meningitis in elderly patients over 65: a hospital-based study. BMC Geriatr. 2011, 11: 91-10.1186/1471-2318-11-91.CrossRefPubMedPubMedCentral Lai WA, Chen SF, Tsai NW, Chang CC, Chang WN, Lu CH, Chuang YC, Chien CC, Huang CR: Clinical characteristics and prognosis of acute bacterial meningitis in elderly patients over 65: a hospital-based study. BMC Geriatr. 2011, 11: 91-10.1186/1471-2318-11-91.CrossRefPubMedPubMedCentral
39.
go back to reference Aronin SI, Peduzzi P, Quagliarello VJ: Community-acquired bacterial meningitis: risk stratification for adverse clinical outcome and effect of antibiotic timing. Ann Intern Med. 1998, 1998 (129): 862-869.CrossRef Aronin SI, Peduzzi P, Quagliarello VJ: Community-acquired bacterial meningitis: risk stratification for adverse clinical outcome and effect of antibiotic timing. Ann Intern Med. 1998, 1998 (129): 862-869.CrossRef
40.
go back to reference Hasbun R, Abrahams J, Jekel J, Quagliarello VJ: Computed tomography of the head before lumbar puncture in adults with suspected meningitis. N Engl J Med. 1993, 345: 1727-1733.CrossRef Hasbun R, Abrahams J, Jekel J, Quagliarello VJ: Computed tomography of the head before lumbar puncture in adults with suspected meningitis. N Engl J Med. 1993, 345: 1727-1733.CrossRef
41.
go back to reference Auburtin M, Wolff M, Charpentier J, Varon E, Le Tulzo Y, Girault C, Mohammedi I, Renard B, Mourvillier B, Bruneel F, Ricard JD, Timsit JF: Detrimental role of delayed antibiotic administration and penicillin-nonsusceptible strains in adult intensive care unit patients with pneumococcal meningitis: the PNEUMOREA prospective multicenter study. Crit Care Med. 2006, 34: 2758-2765. 10.1097/01.CCM.0000239434.26669.65.CrossRefPubMed Auburtin M, Wolff M, Charpentier J, Varon E, Le Tulzo Y, Girault C, Mohammedi I, Renard B, Mourvillier B, Bruneel F, Ricard JD, Timsit JF: Detrimental role of delayed antibiotic administration and penicillin-nonsusceptible strains in adult intensive care unit patients with pneumococcal meningitis: the PNEUMOREA prospective multicenter study. Crit Care Med. 2006, 34: 2758-2765. 10.1097/01.CCM.0000239434.26669.65.CrossRefPubMed
42.
go back to reference Talan D, Zibulewsky J: Relationship of clinical presentation to time to antibiotics for the emergency department management of suspected bacterial meningitis. Ann Emerg Med. 1993, 22: 1733-1738. 10.1016/S0196-0644(05)81314-9.CrossRefPubMed Talan D, Zibulewsky J: Relationship of clinical presentation to time to antibiotics for the emergency department management of suspected bacterial meningitis. Ann Emerg Med. 1993, 22: 1733-1738. 10.1016/S0196-0644(05)81314-9.CrossRefPubMed
43.
go back to reference Andersen J, Backer V, Jensen E, Voldsgaard P, Wandall JH: Acute meningitis of unknown aetiology: analysis of 219 cases admitted to hospital between 1977 to 1990. J Infect. 1995, 31: 113-122. Andersen J, Backer V, Jensen E, Voldsgaard P, Wandall JH: Acute meningitis of unknown aetiology: analysis of 219 cases admitted to hospital between 1977 to 1990. J Infect. 1995, 31: 113-122.
44.
go back to reference Cabellos C, Verdaguer R, Olmo M, Fernández-Sabé N, Cisnal M, Ariza J, Gudiol F, Viladrich PF: Community-Acquired Bacterial Meningitis in Elderly Patients. Experience Over 30 Years. Medicine. 2009, 88: 115-119. 10.1097/MD.0b013e31819d50ef.CrossRefPubMed Cabellos C, Verdaguer R, Olmo M, Fernández-Sabé N, Cisnal M, Ariza J, Gudiol F, Viladrich PF: Community-Acquired Bacterial Meningitis in Elderly Patients. Experience Over 30 Years. Medicine. 2009, 88: 115-119. 10.1097/MD.0b013e31819d50ef.CrossRefPubMed
45.
go back to reference de Gans J, van de Beek D, the European Dexamethasone in Adulthood Bacterial Meningitis Study Investigators: Dexamethasone in adults with bacterial meningitis. N Engl J Med. 2002, 347: 1549-1556. 10.1056/NEJMoa021334.CrossRefPubMed de Gans J, van de Beek D, the European Dexamethasone in Adulthood Bacterial Meningitis Study Investigators: Dexamethasone in adults with bacterial meningitis. N Engl J Med. 2002, 347: 1549-1556. 10.1056/NEJMoa021334.CrossRefPubMed
Metadata
Title
The spectrum of acute bacterial meningitis in elderly patients
Authors
Pere Domingo
Virginia Pomar
Natividad de Benito
Pere Coll
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2013
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-13-108

Other articles of this Issue 1/2013

BMC Infectious Diseases 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.